Panel Endorses Atritech Watchman Stroke-Prevention Device In Close Vote

An FDA advisory committee narrowly elected to recommend approval of Atritech's Watchman minimally invasive stroke-prevention device for atrial fibrillation patients, overcoming doubts about the size of the device's pivotal trial

More from Archive

More from Medtech Insight